Biomarker discovery
Biomarker discovery
Biomarker for aggressive small clear cell renal cell carcinoma
Therapeutic biomarker for aggressive Xp11.2 translocation renal cell carcinoma
Liquid biopsy - ctDNA, cfDNA, ... etc.
DDX11, ALK, ... etc.
Development of New treatment modality
Development of New treatment modality
Oncolytic virus (pexa-vec, JX-594) study
Therapeutic strategy development (combinatorial or sequential)
Microbiome
Microbiome
BPH, prostate cancer,....
Postoperative-ileus
Proteogenomics
Proteogenomics
Development of therapeutic response prediction model in metastatic clear cell renal cell carcinoma patients using serum multi-omics approach
Single-cell analysis
Single-cell analysis
Bladder cancer: BCG response